2016
Incidence of systemic lupus erythematosus in a population-based cohort using revised 1997 American College of Rheumatology and the 2012 Systemic Lupus International Collaborating Clinics classification criteria
Ungprasert P, Sagar V, Crowson C, Amin S, Makol A, Ernste F, Osborn T, Moder K, Niewold T, Maradit-Kremers H, Ramsey-Goldman R, Chowdhary V. Incidence of systemic lupus erythematosus in a population-based cohort using revised 1997 American College of Rheumatology and the 2012 Systemic Lupus International Collaborating Clinics classification criteria. Lupus 2016, 26: 240-247. PMID: 27365370, PMCID: PMC5201452, DOI: 10.1177/0961203316657434.Peer-Reviewed Original ResearchConceptsSystemic lupus erythematosusACR-97SLICC-12Lupus erythematosusSystemic Lupus International Collaborating Clinics classification criteriaSystemic Lupus International Collaborating Clinics (SLICC) groupClassification criteriaIncidence of lupusIncident SLE patientsRenal-limited diseaseSLICC-12 criteriaRochester Epidemiology ProjectACR classification criteriaPopulation-based cohortOlmsted CountyMedian durationSLE patientsAdjusted incidenceAmerican CollegeClinic groupHigh incidenceImmunologic criteriaNeurologic criteriaPatientsIncidence
2015
Autoimmune myelofibrosis with pancytopenia as a presenting manifestation of systemic lupus erythematosus responsive to mycophenolate mofetil
Ungprasert P, Chowdhary V, Davis M, Makol A. Autoimmune myelofibrosis with pancytopenia as a presenting manifestation of systemic lupus erythematosus responsive to mycophenolate mofetil. Lupus 2015, 25: 427-430. PMID: 26537421, DOI: 10.1177/0961203315615221.Peer-Reviewed Original ResearchMeSH KeywordsAdultAutoimmune DiseasesBiopsyFemaleGlucocorticoidsHumansImmunosuppressive AgentsLupus Erythematosus, SystemicMycophenolic AcidPancytopeniaPrednisonePrimary MyelofibrosisTreatment OutcomeConceptsSystemic lupus erythematosusAutoimmune myelofibrosisLupus erythematosusBullous skin lesionsPresenting manifestationPeripheral destructionHematological abnormalitiesSkin lesionsMofetilErythematosusPancytopeniaMyelofibrosisManifestationsLeucopeniaThrombocytopeniaAnemiaGlucocorticoidsLesionsAbnormalitiesEpidemiology of Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus in a Predominantly White Population in the United States
Jarukitsopa S, Hoganson DD, Crowson CS, Sokumbi O, Davis MD, Michet CJ, Matteson EL, Maradit Kremers H, Chowdhary VR. Epidemiology of Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus in a Predominantly White Population in the United States. Arthritis Care & Research 2015, 67: 817-828. PMID: 25369985, PMCID: PMC4418944, DOI: 10.1002/acr.22502.Peer-Reviewed Original ResearchConceptsCutaneous lupus erythematosusSystemic lupus erythematosusSex-adjusted incidenceLupus erythematosusPrevalence of SLEClassic discoid lupus erythematosusBullous lupus erythematosusRochester Epidemiology ProjectSex-adjusted prevalenceDiscoid lupus erythematosusRheumatology classification criteriaWhite populationUS white populationCLE casesOlmsted CountyLupus panniculitisSLE casesMedical recordsErythematosusEpidemiologic studiesAmerican CollegePrevalenceIncidenceOlder adultsAge
2014
Pregnancy‐related issues in women with systemic lupus erythematosus
Singh AG, Chowdhary VR. Pregnancy‐related issues in women with systemic lupus erythematosus. International Journal Of Rheumatic Diseases 2014, 18: 172-181. PMID: 25545844, DOI: 10.1111/1756-185x.12524.Peer-Reviewed Original ResearchConceptsSystemic lupus erythematosusActive diseaseLupus erythematosusPregnancy lossHigh-risk obstetric clinicRisk of flareAdverse pregnancy outcomesCongenital heart blockPregnancy-related issuesRecurrent pregnancy lossIntrauterine growth retardationPersonalized treatment strategiesTime of conceptionMaternal hypertensionActive nephritisAntiphospholipid antibodiesFetal outcomesNeonatal lupusPregnant patientsPreterm deliveryPregnancy outcomesPreterm birthHeart blockNeonatal mortalityAdverse outcomes
2013
Dr. Ludvigsson, et al reply
LUDVIGSSON JF, RUBIO-TAPIA A, CHOWDHARY V, MURRAY JA, SIMARD JF. Dr. Ludvigsson, et al reply. The Journal Of Rheumatology 2013, 40: 1619-1619. PMID: 24137770, DOI: 10.3899/jrheum.130623.Peer-Reviewed Original Research
2012
Chronic Exposure to Staphylococcal Superantigen Elicits a Systemic Inflammatory Disease Mimicking Lupus
Chowdhary VR, Tilahun AY, Clark CR, Grande JP, Rajagopalan G. Chronic Exposure to Staphylococcal Superantigen Elicits a Systemic Inflammatory Disease Mimicking Lupus. The Journal Of Immunology 2012, 189: 2054-2062. PMID: 22798666, PMCID: PMC3462343, DOI: 10.4049/jimmunol.1201097.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsAutoantibodiesAutoantigensAutoimmune DiseasesCD28 AntigensCD4-Positive T-LymphocytesEnzyme-Linked Immunosorbent AssayFlow CytometryFluorescent Antibody TechniqueHLA-DQ AntigensHumansInfusions, SubcutaneousLupus Erythematosus, SystemicMiceMice, TransgenicStaphylococcus aureusSuperantigensConceptsSystemic lupus erythematosusT cellsChronic exposureStaphylococcal enterotoxin BLupus erythematosusMouse MHC class II moleculesHLA-DQ8 transgenic miceMultisystem autoimmune inflammatory diseaseEnterotoxin BHLA-DQ8 miceAutoimmune inflammatory diseaseMHC class II moleculesTh1-type cytokinesMini-osmotic pumpsMononuclear cell infiltrationAnti-nuclear AbsClass II moleculesAbsence of diseaseChronic nasalIL-12Inflammatory infiltrateAutoimmune diseasesCell infiltrationInflammatory diseasesPathogenic roleIncreased Risk of Systemic Lupus Erythematosus in 29,000 Patients with Biopsy-verified Celiac Disease
Ludvigsson JF, Rubio-Tapia A, Chowdhary V, Murray JA, Simard JF. Increased Risk of Systemic Lupus Erythematosus in 29,000 Patients with Biopsy-verified Celiac Disease. The Journal Of Rheumatology 2012, 39: 1964-1970. PMID: 22859356, PMCID: PMC3463642, DOI: 10.3899/jrheum.120493.Peer-Reviewed Original ResearchMeSH KeywordsAdultCeliac DiseaseComorbidityFemaleHumansIncidenceLupus Erythematosus, SystemicMaleMiddle AgedPrevalenceRegistriesRiskSwedenConceptsSystemic lupus erythematosusRisk of SLEHazard ratioCeliac diseaseLupus erythematosusAbsolute riskExcess riskGeneral populationPossible associationBiopsy-verified celiac diseaseIncident systemic lupus erythematosusSweden's 28 pathology departmentsSwedish Total Population RegisterDepartment of RheumatologySwedish Patient RegisterYears of followupPopulation-based studyTotal Population RegisterSimilar risk estimatesSLE diagnosisPatient RegisterCase seriesCox regressionCD diagnosisPathology department
2008
Liver Involvement in Systemic Lupus Erythematosus: Case Review of 40 Patients
Chowdhary VR, Crowson CS, Poterucha JJ, Moder KG. Liver Involvement in Systemic Lupus Erythematosus: Case Review of 40 Patients. The Journal Of Rheumatology 2008, 35: 2159-2164. PMID: 18793002, DOI: 10.3899/jrheum.080336.Peer-Reviewed Original ResearchConceptsSystemic lupus erythematosusEndstage liver diseaseLiver diseasePortal hypertensionLiver involvementViral hepatitisLupus erythematosusLiver disease-free survivalNonalcoholic fatty liver diseaseCoexistent liver diseaseSubclinical liver involvementDevelopment of cirrhosisLiver enzyme abnormalitiesAlanine aminotransferase levelsDisease-free survivalRetrospective chart reviewCohort of patientsFatty liver diseasePrimary biliary cirrhosisAlkaline phosphatase levelsClinical diagnostic groupsAutoimmune hepatitisCryptogenic cirrhosisHepatitis CAminotransferase levels
2007
Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus
Chowdhary V, Grande J, Luthra H, David C. Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus. Rheumatology 2007, 46: 1405-1410. PMID: 17576695, DOI: 10.1093/rheumatology/kem117.Peer-Reviewed Original ResearchConceptsAnti-neutrophil cytoplasm antibodiesBronchoalveolar lavagePulmonary capillaritisAntinuclear antibodiesIL-10IL-6IL-4IL-2TNF-alphaIFN-gammaPhosphate-buffered saline injectionEvidence of vasculitisLupus-specific autoantibodiesPristane-induced lupusPristane-injected miceImmune complex depositionSingle intraperitoneal injectionDifferential cell countsPristane injectionAlveolar inflammationCytokine levelsCytoplasm antibodiesLupus lesionsNeutrophil infiltrationEndothelial injury